SCHEMBL22947252

SCHEMBL22947252

c1ccc(-c2nc(-c3ccccc3)nc(-c3c4ccccc4c(-c4ccc5c(c4)-c4ccccc4[Si]5(c4ccccc4)c4ccccc4)c4ccccc34)n2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
ALDH1A1 P00352 3/20 0.34
MAPT P10636 3/20 0.34
HPGD P15428 3/20 0.34
ATM Q13315 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.32
TSHR P16473 2/20 0.31
ADORA3 P0DMS8 1/20 0.31
ALOX15 P16050 1/20 0.31
ADORA2A P29274 1/20 0.31
ADORA2B P29275 1/20 0.31
ADORA1 P30542 1/20 0.31
NTSR1 P30989 1/20 0.31
KDM4E B2RXH2 2/20 0.31
TP53 P04637 1/20 0.31
NFKB1 P19838 1/20 0.31
MAPK1 P28482 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22947581 0.92 MEN1 (0.34) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL22947216 0.88 MEN1 (0.40) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL22947258 0.88 L3MBTL1 (0.33) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL22949569 0.86 MEN1 (0.39) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL22949298 0.86 MEN1 (0.39) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL22947279 0.86 MEN1 (0.39) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL31040335 0.86 MEN1 (0.39) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL22948261 0.86 RORA (0.37) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL22948260 0.85 RORA (0.36) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL22947413 0.85 RORA (0.36) MEN1KMT2AALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036245-A1 HETEROAROMATIC COMPOUNDS MERCK PATENT GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036245-A1 HETEROAROMATIC COMPOUNDS ETV6, FES, LEF1 MEN1 2439/4885KMT2A 2115/4885ALDH1A1 752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.